Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.0B | 4.6B | 4.5B | 4.5B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 511M | 532M | 466M | 394M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 38M | 35M | 37M | 35M |
| Other income expense | 80M | 51M | 18M | 13M |
| Pretax income | 1.4B | 678M | 937M | 1.1B |
| Tax provision | 214M | 121M | 66M | 98M |
| Net income | 1.2B | 574M | 935M | 988M |
| Basic EPS | 3.3 | 1.5 | 2.5 | 2.6 |
| Diluted EPS | 3.2 | 1.5 | 2.4 | 2.6 |
| Basic average shares | 372.2M | 372.9M | 373.3M | 373.2M |
| Diluted average shares | 379.9M | 381.9M | 382.8M | 382.3M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 1.2B | 574M | 935M | 988M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |